Preferred Label : Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency;
CISMeF acronym : CAH1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Adrenal hyperplasia III; 21-hydroxylase deficiency; Cyp21 deficiency; Congenital adrenal hyperplasia 1; CAH1;
Included titles and symbols : Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency;
Description : Congenital adrenal hyperplasia (CAH) results from a deficiency in one or another of
the enzymes of cortisol biosynthesis. In about 95% of cases, 21-hydroxylation is impaired
in the zona fasciculata of the adrenal cortex so that 17-hydroxyprogesterone (17-OHP)
is not converted to 11-deoxycortisol. Because of defective cortisol synthesis, ACTH
levels increase, resulting in overproduction and accumulation of cortisol precursors,
particularly 17-OHP, proximal to the block. This causes excessive production of androgens,
resulting in virilization. Slominski et al. (1996) presented evidence that the CYP21A2,
CYP11A1 (118485), CYP17 (609300), and ACTHR (202200) genes are expressed in skin (see
202200). The authors suggested that expression of these genes may play a role in skin
physiology and pathology and that cutaneous proopiomelanocortin activity may be autoregulated
by a feedback mechanism involving glucocorticoids synthesized locally.;
Inheritance : Autosomal recessive;
Prefixed ID : #201910;
Origin ID : 201910;
UMLS CUI : C2936858;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
Validated automatic mappings to NTBT